Stirol’s pharmaceutical division to increase capacity in 2011
10 March 2011
Stirolbiofarm, the pharmaceutical branch of Stirol (UX: STIR UK) is planning to increase pill production capacity this year by 67% as a result of modernization, Interfax reported yesterday, citing an industry publication. Antonina Davydenko: Assuming the modernization and new capacity installation happen as planned, Stirolbiofarm could increase its top line by 1.5x in 2011, adding around UAH 30 mln to sales, resulting in a 1-2% boost in sales for its parent company Stirol.
